AIM
AMPH icon

Anchor Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Anchor Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75
Closed -$1.72K – 1067
2025
Q2 		$1.72K Sell
75
-75
-50% -$1.86K ﹤0.01% 970
2025
Q1 		$4.35K Hold
150
– – ﹤0.01% 898
2024
Q4 		$5.57K Buy
+150
New +$6.86K ﹤0.01% 868

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Anchor Investment Management's AMPH Position: Q3 2025 in Review

Anchor Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2025, closing a stake of 75 shares — an estimated $1.72K sold.

Anchor Investment Management first reported a position in AMPH in Q4 2024 and held it in 3 quarters. The position peaked at $5.57K in Q4 2024. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

  • Anchor Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Anchor Investment Management sold 75 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $1.72K.
  • Anchor Investment Management first reported a position in Amphastar Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Anchor Investment Management's Amphastar Pharmaceuticals position peaked at $5.57K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Anchor Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.